BIOACCEL ANNOUNCES MAJOR FUNDING FROM ECONOMIC DEVELOPMENT ADMINISTRATION FOR DEVELOPING EARLY-STAGE INVESTMENT ECOSYSTEM IN ARIZONA AND SOUTHWESTERN U.S. Continue reading
Category Archives: AZBio News
ASU’s Dr. Qiang Chen on what to expect from the latest global health concern
Qiang “Shawn” Chenis an ASU Biodesign Institute researcher and School of Life School Sciences professor, Center for Infectious Diseases and Vaccinology.
ARIZONA INNOVATION CHALLENGE – Spring 2016
The ARIZONA INNOVATION CHALLENGE (AIC) Spring 2016 Round Opens Monday February 8,2016. Up to 6 Companies will Win Up to $250,000 each.Continue reading
HB 2310- Getting Ready for Biosimilars in Arizona
The FDA approved the first biosimilar in the U.S. in March of 2015 with more expected to be approved in 2016. Now, on a state by state basis, the laws that govern how these new therapies can be dispensed are being updated. Arizona has the opportunity to do so in 2016 with HB 2310 sponsored by Dr. Regina Cobb, Vice Chairman of the House Health Committee.Continue reading
Flagship Biosciences Creates Clinical Trials and Regulatory Affairs Group
Flagship Biosciences created a Clinical Trials and Regulatory Affairs Group and partners with DOCRO, Inc., an industry leader for IVD clinical trials and regulatory affairs, to bring image analysis based Companion Diagnostics (CDx) into the clinical market. Continue reading
Cancer Moon Shot 2020
Historic National Coalition formed to accelerate next generation immunotherapy in cancer careContinue reading
ASU names LaBaer interim executive director of the Biodesign Institute
Dr. Joshua L. LaBaer, named interim executive director for the Biodesign Institute at Arizona State University.
TGen study targets SGEF protein in treating glioblastoma brain tumors
Study funded by Ivy Foundation shows SGEF plays roles in how cancer cells survive and invade brain tissueContinue reading
$190 M Licensing Deal Announced with Cancer Prevention Pharmaceuticals
SUCAMPO ENTERS INTO EXCLUSIVE OPTION AND COLLABORATION AGREEMENT WITH CANCER PREVENTION PHARMACEUTICALS FOR DEVELOPMENT OF LATE-STAGE CPP-1X/SULINDAC COMBINATION FOR FAMILIAL ADENOMATOUS POLYPOSIS
Spicy Arthritis Treatment Moves to Clinical Trials
A UA research team studying the anti-inflammatory impact of turmeric is moving the project out of the laboratory and into patient testing. (Source)Continue reading